Optimization of the benzamide fragment targeting the S2′ site leads to potent dipeptidyl peptidase-IV inhibitors
Xiaoyan Deng(Guangxi Medical University), Qing Li(Guangxi Medical University), Linhong He(Guangxi Medical University), Liuwei Meng(Guangxi Medical University), Na Wang(Union Hospital), Junhao Xing(China Pharmaceutical University), Siru Zhou(National Chung Cheng University), Junli Huang(Guangxi Medical University), Weizhe Jiang(Guangxi Medical University)
Cited by 12
Related Papers
<i>TERT</i> promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA
|Cancer|2014|114
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression
|International Journal of Molecular Sciences|2024|80
“Learning” Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus
|Diabetes Technology & Therapeutics|2017|54
FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling
|PLoS Genetics|2015|51
Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation
|The Journal of Pathology|2019|51